Nan Fung Group Holdings »

Evommune shares owned by Nan Fung Group Holdings

Quarter-by-quarter ownership of Evommune (EVMN) shares owned by Nan Fung Group Holdings from 13F filings

Historical chart of Nan Fung Group Holdings investment in Evommune

Tip: Access up to 7 years of quarterly data

All positions including Evommune held by Nan Fung Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evommune by Nan Fung Group Holdings

Quarter filed Position value Share count Share price at filing
2025-12-31 $25M 1.4M 17.12

More positions owned by Nan Fung Group Holdings

Evommune Com Shs (EVMN)
Maplight Therapeutics (MPLT)
Oculis Holding Ordinary Shares (OCS)
Madrigal Pharmaceuticals (MDGL)
Lb Pharmaceuticals Com Shs (LBRX)
Incyte Corporation (INCY)
Rhythm Pharmaceuticals (RYTM)
Beone Medicines Sponsored Ads (ONC)
Procore Technologies (PCOR)
Cybin Com New (HELP)
Ascendis Pharma A/s Sponsored Adr (ASND)
ACADIA Pharmaceuticals (ACAD)
Recursion Pharmaceuticals In Cl A (RXRX)
D Fluidigm Corp Del (LAB)
Kymera Therapeutics (KYMR)

View all positions for Nan Fung Group Holdings

Top funds holding Evommune

EQT Fund Management S.a r.l.
Pivotal bioVenture Partners Investment Advisor
Nan Fung Group Holdings
Rtw Investments
Marshall Wace
Eventide Asset Management
Sectoral Asset Management
Verition Fund Management
Standard Life Aberdeen
Vanguard Group
Octagon Capital Advisors
American Century Companies
Federated Investors
Dr. Jeffrey R. Jay, M.D.
Kynam Capital Management

View all funds holding Evommune